| 肝素钙预防过敏性紫癜患儿肾损害临床观察与分析 |
| |
| 引用本文： | 潘伟,徐进生. 肝素钙预防过敏性紫癜患儿肾损害临床观察与分析[J]. 中国实用儿科杂志, 2001, 16(4): 205 |
| |
| 作者姓名： | 潘伟 徐进生 |
| |
| 作者单位： | 江苏省江阴市人民医院儿科214400 |
| |
| 基金项目： | 江苏省科委社会发展项目!BS(99313) |
| |
| 摘 要： | 探讨过敏性紫癜患儿应用肝素钙预防肾损害的有效性、可行性。方法将59例过敏性紫癜患儿随机分成肝素钙治疗组和对照治疗组，另设非HSP对照组20例，追踪监测尿β
|
| 关 键 词： | 肝素紫癜，过敏性 |
| 文章编号： | l005-2224(2001)04-0205-02 |
| 修稿时间： | 2000-10-30 |
Clinical observation andanalysis of heparin calcium as a precaution against kidney involvements in HenochSchonlein purpura patients |
| |
| Abstract: | Objective To explore the effectivity and feasibility of heparincalcium as a precaution against kidney involvements in Henoch-Schonlein purpura patients. Methods The 59 HSP patients were divided into the heparin calcium treated group and the control group at random. β2-M and Alb of urine were monitored constantly. Results No significant differences were found between the two groups in β2-M and Alb of urine before treatment ( P＞0. 05 ). The two indexes of the heparin calcium treated group were lower than that of the control group after 3 and 6 months' treatment,and significant differences could be observed( P ＜ 0.01 ). As to Alb of urine, there were no significant differences between the heparin calciunm treated group and the non-HSP group after 6 months' treatment( P＞0.05 ). Conclusions Heparin calcium can be used to protect against kidney involvements in HSP patients safely. |
| |
| Keywords: | Heparin Purpura allergic |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
